ROBERT GUTIERREZ: Open Payments
NPI 1528292398 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 7 payments from 6 companies in 2025. Trend: 2023 $632 · 2024 $1,855 · 2025 $731
Food & beverage: $731
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $207 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $111 |
| Neurocrine BioSciences, Inc. | 1 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $97 |
| Amgen Inc. | 1 | $94 |
Products named: Kerendia, CAPLYTA, Wegovy, Ozempic, XIFAXAN, REPATHA.
Industry payments across TX — which companies pay providers there.
